Contact Us: 1-518-583-0095 
We’re Hiring… Join Our Team!
Stay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia. Learn about new treatment guidelines for bladder cancer, promising results from a novel treatment for prostate cancer, and more.
Continue readingStay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia. Learn about a new radiopharmaceutical therapy for neuroendocrine tumors, the role of AI in breast cancer diagnosis and treatment, and more.
Continue readingStay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia. Learn about new therapies in non-small cell lung cancer, personalized medicine approaches for cancer treatment, and more.
Continue readingStay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia. Learn about nanoparticles enhancing radiation therapy in lung cancer, a new study focusing on ER+/HER2 breast cancer, and more.
Continue readingStay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia, highlighting patient empowerment in clinical trials and a successful therapy for patients with metastatic breast cancer.
Continue readingStay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia.
Continue readingStay up-to-date with recent advances in oncology research and care from members of Criterium’s Oncology Consortia.
Continue readingMike Cusnir, M.D. discusses research and treatments for patients with metastatic hormone-sensitive prostate cancer, and Jeremy Cetnar, M.D. provides insights on lung cancer’s prevalence in women.
Continue reading
Congratulations to Wells Messersmith, MD, Director of Criterium’s Academic GI Cancer Consortium (AGICC) on his appointment to the National Cancer Institute’s Board of Scientific Advisors.
Continue reading
Dr. Deirdre Cohen and Dr. Robert Lentz, principal investigators with the Academic GI Cancer Consortium, attended the ASCO 2024 Annual Conference and shared valuable insights and progress from their innovative research model and clinical trials.
Continue reading